Close Menu

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technical and Regulatory Considerations for Designing Next-Generation Sequencing Controls and Standards for Optimal Quality and Performance: A Panel Discussion.

Presented by Russell Garlick PhD - CSO LGC Clinical Diagnostics SeraCare LIfe Sciences
Karen Gutekunst PhD - VP of Regulatory Affairs Illumina
Bob Daber PhD - President and CTO Genosity
Federico Goodsend PhD - Principal Regulatory Pathfinders LLC
Jinjie Hu PhD - Principal Consultant for Axteria BioMed

Sponsored by

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.